Milestone Pharmaceuticals

+$0.29 (+5.51%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MIST and other stocks, options, and ETFs commission-free!

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that designed as a rapid-onset nasal spray to be self-administered by patients.

CEO
Joseph G. Oliveto
Employees
28
Headquarters
Montréal, Québec
Founded
2003

MIST Key Statistics

Market Cap
175.41M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
53.61K
High Today
$5.77
Low Today
$5.25
Open Price
$5.36
Volume
95.79K
52 Week High
$11.40
52 Week Low
$3.07

MIST Earnings

-$0.75
-$0.50
-$0.25
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market

You May Also Like

UDOW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure